Leflunomide

Table   Graphic     exposition period:

Congenital malformations
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
All congenital malformations (majors, minors, majors and minors, or unspecified)0.97 [0.81, 1.16]0%3 studies14,378116not evaluable ROB-
Major congenital malformations0.97 [0.81, 1.16]0%3 studies14,378116not evaluable ROB-
Microcephaly / Small head circumference for gestational age0.62 [0.21, 1.84]-1 study1856not evaluable ROB-
Minor congenital malformations1.87 [0.92, 3.79]-1 study5351not evaluable ROB-
Congenital heart defects3.11 [0.99, 9.77]-1 studynot evaluable ROB-
Limb defects1.38 [0.96, 1.98]-1 studynot evaluable ROB-

Growth parameters and prematurity
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
Preterm (< 37 weeks)2.04 [1.07, 3.90]0%2 studies10,86877not evaluable ROB3.50 [1.33; .]
Low birth weight (< 2500g)1.06 [0.90, 1.25]0%2 studies23not evaluable ROB-
Small for gestational age (length)0.40 [0.08, 1.97]-1 study1056not evaluable ROB-
Small for gestational age (weight)2.08 [0.75, 5.75]-1 study1756not evaluable ROB-

Maternal consequences
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
Caesarean--0 study-
Gestational diabetes2.63 [0.43, 16.26]-1 study556not evaluable ROB-
Preeclampsia3.68 [0.88, 15.35]-1 study956not evaluable ROB-

Long term consequences
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
Child/Infant head circumference abnormalities (> 1 year)0.94 [0.30, 2.95]-1 study1456not evaluable ROB-
Child/Infant lenght abnormalities (> 1 year)2.57 [0.78, 8.53]-1 study1256not evaluable ROB-
Child/Infant weight abnormalities (> 1 year)1.05 [0.41, 2.72]-1 study2156not evaluable ROB-

Intrauterine deaths
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
Early intrauterine death (< 22 weeks)1.09 [0.90, 1.32]0%2 studies17,747112not evaluable ROB-
Elective/induced termination of pregnancy0.84 [0.07, 9.44]-1 study363not evaluable ROB-
Late intrauterine deaths (> 22 weeks)0.56 [0.02, 13.89]-1 study163not evaluable ROB-
Intrauterine deaths (as a whole or unspecified)1.13 [0.08, 16.31]-1 study53not evaluable ROB-

Neuro-developmental disorders
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value

Hide endpoints reported in only one study ...